“In terms of sector preferences, large private banks are currently experiencing an advantage of fall in the Net Interest Margins (NIMs), although they maintain robust credit growth and stable asset quality. Most of these banks are well-capitalized, and their valuations align with historical averages. Meanwhile, the pharmaceutical sector is showing resilience with steady performance in the domestic market.”
| Subscribe To Our Free Newsletter |
